100
Participants
Start Date
September 20, 2019
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Lasofoxifene
Estrogen receptor antagonist antineoplastic agent
Fulvestrant
Estrogen receptor antagonist antineoplastic agent
Roswell Park Comprehensive Cancer Center, Buffalo
UPMC Hillman Cancer Center, Pittsburgh
FMH James M Stockman Cancer Institute (JIT), Frederick
Peninsula Cancer Institute, Newport News
Duke University Medical Center, Durham
Emory University, Atlanta
Mayo Clinic Florida, Jacksonville
Florida Cancer Specialists, Tallahassee
Miami Cancer Institute, Miami
The Bond Clinic Cancer & Research Center., Winter Haven
Ocala Oncology Center (JIT), Ocala
Tennessee Oncology/SCRI, Nashville
Tennessee Oncology Chattanooga, Chattanooga
West Cancer Center, Germantown
Hattiesburg Clinic Hematology/Oncology, Hattiesburg
University of Louisville / James Graham Brown Cancer Center, Louisville
The Ohio State University - Comprehensive Cancer Center, Columbus
Ohio Health (JIT), Columbus
TriHealth Cancer Institute, Cincinnati
Beacon Health (JIT), South Bend
Rabin Medical Center, Petah Tikva
Mayo Clinic, Rochester
Sanford Cancer Center (JIT), Sioux Falls
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
University of Chicago, Chicago
Illinois Cancer Care (JIT), Peoria
Carle Cancer Center, Urbana
Washington University School of Medicine, St Louis
Saint Luke's Cancer Institute, Kansas City
HCA Midwest Health, Kansas City
Mary Crowley Cancer Research (JIT), Dallas
Oncology Consultants (JIT), Houston
Rocky Mountain Cancer Centers, Longmont
Soroka University Medical Center, Beersheba
Utah Cancer Specialists (JIT), Salt Lake City
Mayo Clinic Arizona, Phoenix
Yuma Regional Medical Center (JIT), Yuma
Comprehensive Cancer Centers of Nevada (JIT), Las Vegas
City of Hope Comprehensive Cancer, Duarte
Compassionate Care Research Group, Fountain Valley
UCSF Cancer Center, San Francisco
Hawaii Cancer Care (JIT), Honolulu
Hadassah Ein Kerem Medical Center, Jerusalem
Sheba Medical Center, Ramat Gan
New Jersey Cancer Care and Blood Disorders (JIT), Belleville
Summit Medical Group (JIT), Florham Park
The Ottawa Hospital, Ottawa
Sunnybrook Health Sciences Center, Toronto
CIUSSS de Saguenay-Lac-Saint Jean, Chicoutimi
Jewish General Hospital, Montreal
McGill University Health Centre, Montreal
Linical Accelovance Group
UNKNOWN
Sermonix Pharmaceuticals Inc.
INDUSTRY